See the light: Can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort?

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 1, 2014, Pages 17-20

  Boyle, Patrick M ^a   Entcheva, Emilia ^b   Trayanova, Natalia A ^a  

^a Johns Hopkins University   (United States)

^b St Francis Hospital The Heart Center   (United States)

Author keywords

arrhythmia; cardioversion; cell therapy; defibrillation; direct His bundle pacing; gene therapy; optogenetics

Indexed keywords

GLASS FIBER; OPSIN;

CELL THERAPY; CELLULAR DISTRIBUTION; CLINICAL TRIAL (TOPIC); ELECTROSTIMULATION THERAPY; GENE THERAPY; GENETIC TRANSDUCTION; HEART ARRHYTHMIA; HEART BEAT; HEART MUSCLE CELL; HUMAN; LIGHT; MOLECULAR BIOLOGY; NONHUMAN; OPTOGENETICS; REVIEW; VIRUS INFECTION;

HEART; HEART DISEASES; HUMANS; ION CHANNELS; LIGHT; OPTOGENETICS; PROTEINS;

EID: 84893151493     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.864951     Document Type: Review

References (20)

1. Entcheva E. Cardiac optogenetics. Am. J. Physiol. Heart Circ. Physiol. 304(9), H1179-H1191 (2013).
2. Abilez OJ, Wong J, Prakash R, Deisseroth K, Zarins CK, Kuhl E. Multiscale computational models for optogenetic control of cardiac function. Biophys. J. 101(6), 1326-1334 (2011).
3. Jia Z, Valiunas V, Lu Z et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ. Arrhythm. Electrophysiol. 4(5), 753-760 (2011).
4. Bruegmann T, Malan D, Hesse M et al. Optogenetic control of heart muscle in vitro and in vivo. Nat. Methods 7(11), 897-900 (2010).
5. Boyle PM, Williams JC, Ambrosi CM, Entcheva E, Trayanova NA. A comprehensive multiscale framework for simulating optogenetics in the heart. Nat. Commun. 4, 2370 (2013).
6. Williams JC, Xu J, Lu Z et al. Computational Optogenetics: empirically-Derived Voltage-and Light-Sensitive Channelrhodopsin-2 Model. PLoS Comput. Biol. 9(9), e1003220 (2013).
7. Jessup M, Greenberg B, Mancini D et al. Calcium Upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124(3), 304-313 (2011).
8. Bolli R, Chugh AR, D'amario D et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378(9806), 1847-1857 (2011).
9. Rosen AB, Kelly DJ, Schuldt AJ et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 25(8), 2128-2138 (2007).
10. Prasad KM, Smith RS, Xu Y, French BA. A single direct injection into the left ventricular wall of an adeno-associated virus (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. J. Gene Med. 13(6), 333-341 (2011).
11. Baxter WT, Mironov SF, Zaitsev AV, Jalife J, Pertsov AM. Visualizing excitation waves inside cardiac muscle using transillumination. Biophys. J. 80(1), 516-530 (2001).
12. Nikolic K, Grossman N, Grubb MS, Burrone J, Toumazou C, Degenaar P. Photocycles of channelrhodopsin-2. Photochem. Photobiol. 85(1), 400-411 (2009).
13. Kim RH, Kim DH, Xiao J et al. Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat. Mater. 9(11), 929-937 (2010).
14. Lin JY, Knutsen PM, Muller A, Kleinfeld D, Tsien RY. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat. Neurosci. 16(10), 1499-1508 (2013).
15. Epstein AE, Dimarco JP, Ellenbogen KA et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 127(3), e283-352 (2013).
16. Tsubota T, Ohashi Y, Tamura K, Sato A, Miyashita Y. Optogenetic manipulation of cerebellar Purkinje cell activity in vivo. PLoS ONE 6(8), e22400 (2011).
17. Barba-Pichardo R, Manovel Sanchez A, Fernandez-Gomez JM, Morina-Vazquez P, Venegas-Gamero J, Herrera-Carranza M. Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator. Europace 15(1), 83-88 (2013).
18. Merrill DR, Bikson M, Jefferys JG. Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J. Neurosci. Methods 141(2), 171-198 (2005).
19. McDowell KS, Vadakkumpadan F, Blake R et al. Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation. Biophys. J. 104(12), 2764-2773 (2013).
20. Jung J, Hahn SJ, Heisel A, Buob A, Schubert BD, Siaplaouras S. Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation. J. Cardiovasc. Electrophysiol. 14(8), 837-840 (2003).